Skip to main
BLND
BLND logo

Blend Labs (BLND) Stock Forecast & Price Target

Blend Labs (BLND) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 43%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Blend Labs Inc. is experiencing a positive outlook driven by a robust 18% year-over-year increase in its pipeline, which now captures over 4% of the 2024 HMDA market share. The company's recent introduction of the Rapid Refi product is anticipated to enhance profitability by facilitating quicker loan closings, thereby increasing the average economic value per loan. Furthermore, Blend's Q2 results highlight significant revenue growth in its consumer banking suite, evidenced by a 43% rise in this segment, even amid a decline in mortgage suite revenue, suggesting effective optimization in a low-volume mortgage environment.

Bears say

Blend Labs Inc. is facing a significant and larger-than-anticipated reduction in mortgage volumes, which may adversely impact its financial performance. The decline in mortgage economic value per funded loan has dropped from $93 to $88, attributed to transitions in its partnership model for homeowner insurance and income verification. Additionally, the ongoing expectations of rising interest rates over the next 2-3 years compound the challenges, as this could further depress mortgage activity and hinder the company’s ability to achieve its operational targets.

Blend Labs (BLND) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Blend Labs and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Blend Labs (BLND) Forecast

Analysts have given Blend Labs (BLND) a Buy based on their latest research and market trends.

According to 7 analysts, Blend Labs (BLND) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Blend Labs (BLND)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.